课题基金 / 基金详情

The role of ERRalpha in mitochondrial function and insulin resistance

The role of ERRalpha in mitochondrial function and insulin resistance
ERRalpha 在线粒体功能和胰岛素抵抗中的作用
批准号:
7230096
负责人:
Anastasia Kralli
金额:
$27.08万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2009-03-31

项目摘要

项目成果

Anastasia Kralli的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):2型糖尿病是西方和发展中国家最常见的代谢紊乱,迅速成为世界性流行病。虽然2型糖尿病的确切主要原因(S)尚未确定,但很明显,胰岛素抵抗,即胰岛素无法促进葡萄糖代谢,在疾病的发展中起着重要作用。线粒体氧化功能降低和随之而来的细胞内脂肪堆积增加被认为是胰岛素抵抗的根本原因。值得注意的是,胰岛素抵抗或2型糖尿病患者的肌肉中编码线粒体蛋白的基因表达减少,线粒体和线粒体酶的含量降低,线粒体氧化磷酸化能力降低。最近的研究阐明了控制线粒体功能的特定转录网络。目前尚不清楚这些网络的扰动在多大程度上促进了胰岛素抵抗和糖尿病的发展。这项拟议的工作将检验孤儿核受体雌激素相关受体α(ERRA)是体内调节骨骼肌线粒体氧化能力和胰岛素敏感性的关键转录因子的假设。为了支持这一假说,Erra被刺激肌肉中线粒体生物发生和功能的信号和途径激活,Erra调节培养细胞中线粒体的生物发生和功能,而缺乏Erra的小鼠(Erra KO)减少了线粒体蛋白编码基因的表达。为了验证我们的假设,我们将1)比较野生型和Erra KO小鼠肌肉中线粒体的生物发生和功能,以确定Erra在骨骼肌线粒体功能中的作用;2)评估Erra对野生型和Erra KO小鼠以及具有或缺乏Erra KO小鼠的原代肌肉细胞培养的胰岛素敏感性的影响。我们期望证明ERRA调节肌肉线粒体新陈代谢,并在2型糖尿病前的胰岛素抵抗的发展中发挥重要作用。这些研究将使旨在恢复线粒体功能、改善胰岛素抵抗和预防糖尿病相关病理的治疗策略的开发成为可能。与公共卫生的相关性。糖尿病是世界范围内的一个主要健康问题,已达到流行的程度。胰岛素抵抗在2型糖尿病的发展中起着重要作用,2型糖尿病是最常见的疾病形式。这项拟议的工作使用动物模型来确定转录调控因子Erra在体内控制线粒体功能和确定胰岛素敏感性的程度。建立线粒体功能降低和胰岛素抵抗易感性的动物模型将有助于评估改善胰岛素敏感性和降低糖尿病发病率的策略。
英文摘要
DESCRIPTION (provided by applicant): Type 2 diabetes is the most prevalent metabolic disorder in Western and developing countries, rapidly becoming a worldwide epidemic. Although the exact primary cause(s) of type 2 diabetes are not yet defined, it is clear that insulin resistance, i.e. the inability of insulin to promote glucose disposal, plays a major role in the development of the disease. Decreased mitochondrial oxidative function and an ensuing increased intracellular lipid accumulation have been proposed as underlying causes for insulin resistance. Notably, muscle in individuals with insulin resistance or type 2 diabetes has decreased expression of genes encoding mitochondrial proteins, lower content of mitochondria and mitochondrial enzymes, and reduced mitochondrial oxidative phosphorylation capacity. Recent studies have elucidated specific transcriptional networks that control mitochondrial function. The extent to which perturbations in these networks contribute to insulin resistance and the development of diabetes is currently not clear. The proposed work will test the hypothesis that the orphan nuclear receptor Estrogen Related Receptor alpha (ERRa) is a critical transcription factor regulating mitochondrial oxidative capacity and insulin sensitivity in skeletal muscle in vivo. In support of the hypothesis, ERRa is activated by signals and pathways that stimulate mitochondrial biogenesis and function in muscle, ERRa regulates mitochondrial biogenesis and function in cultured cells, and mice lacking ERRa (ERRa KO) have decreased expression of genes encoding mitochondrial proteins. To test our hypothesis we will 1) compare mitochondrial biogenesis and function in muscle of wild-type and ERRa KO mice to determine the role of ERRa in mitochondrial function in skeletal muscle; and 2) assess the effect of ERRa on insulin sensitivity in wild-type and ERRa KO mice, and in primary muscle cell cultures having or lacking ERRa. We expect to demonstrate that ERRa regulates muscle mitochondrial metabolism and plays an important role in the development of the insulin resistance that precedes type 2 diabetes. These studies will enable development of therapeutic strategies aiming at restoring mitochondrial function, ameliorating insulin resistance and preventing diabetes-associated pathologies. Relevance to public health. Diabetes is a major health problem worldwide, reaching epidemic proportions. Insulin resistance plays a major role in the development of type 2 diabetes, i.e. the most prevalent form of the disease. The proposed work uses animal models to determine the extent to which the transcriptional regulator ERRa controls mitochondrial function and determines insulin sensitivity in vivo. Establishment of an animal model with decreased mitochondrial function and susceptibility to insulin resistance will be useful for evaluating strategies that improve insulin sensitivity and decrease the incidence of diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulators of adipocyte oxidative metabolism
  • 批准号:
    10632187
  • 项目类别:
  • 资助金额:
    $2.48万
  • 财政年份:
    2022
  • 负责人:
    Anastasia Kralli
  • 依托单位:
Regulators of adipocyte oxidative metabolism
  • 批准号:
    10391144
  • 项目类别:
  • 资助金额:
    $45.03万
  • 财政年份:
    2021
  • 负责人:
    Anastasia Kralli
  • 依托单位:
Regulators of adipocyte oxidative metabolism
  • 批准号:
    10532240
  • 项目类别:
  • 资助金额:
    $45.03万
  • 财政年份:
    2021
  • 负责人:
    Anastasia Kralli
  • 依托单位:
Regulators of adipocyte oxidative metabolism
  • 批准号:
    10673362
  • 项目类别:
  • 资助金额:
    $7.43万
  • 财政年份:
    2021
  • 负责人:
    Anastasia Kralli
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: